- Home
- EVOK vs NUWE Comparison
EVOK vs NUWE Comparison
Compare EVOK & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- NUWE
- Stock Information
- Founded
- EVOK 2007
- NUWE 1999
- Country
- EVOK United States
- NUWE United States
- Employees
- EVOK N/A
- NUWE N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- EVOK Health Care
- NUWE Health Care
- Exchange
- EVOK Nasdaq
- NUWE Nasdaq
- Market Cap
- EVOK 7.7M
- NUWE 3.9M
- IPO Year
- EVOK 2013
- NUWE N/A
- Fundamental
- Price
- EVOK $3.85
- NUWE $10.59
- Analyst Decision
- EVOK
- NUWE Strong Buy
- Analyst Count
- EVOK 0
- NUWE 1
- Target Price
- EVOK N/A
- NUWE $714.00
- AVG Volume (30 Days)
- EVOK 7.2M
- NUWE 2.3M
- Earning Date
- EVOK 08-12-2025
- NUWE 08-12-2025
- Dividend Yield
- EVOK N/A
- NUWE N/A
- EPS Growth
- EVOK N/A
- NUWE N/A
- EPS
- EVOK N/A
- NUWE N/A
- Revenue
- EVOK $11,594,083.00
- NUWE $8,787,000.00
- Revenue This Year
- EVOK $57.82
- NUWE $6.53
- Revenue Next Year
- EVOK $59.12
- NUWE $51.63
- P/E Ratio
- EVOK N/A
- NUWE N/A
- Revenue Growth
- EVOK 89.89
- NUWE N/A
- 52 Week Low
- EVOK $1.94
- NUWE $6.33
- 52 Week High
- EVOK $12.32
- NUWE $175.98
- Technical
- Relative Strength Index (RSI)
- EVOK 46.17
- NUWE 41.26
- Support Level
- EVOK $4.26
- NUWE $10.10
- Resistance Level
- EVOK $4.70
- NUWE $16.50
- Average True Range (ATR)
- EVOK 0.43
- NUWE 2.07
- MACD
- EVOK -0.15
- NUWE 0.48
- Stochastic Oscillator
- EVOK 4.80
- NUWE 21.71
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.